Lake Street Downgrades QuinStreet to Hold
Lake Street analyst Eric Martinuzzi downgrades QuinStreet (NASDAQ:QNST) from Buy to Hold.
QuinStreet: Q2 Earnings Insights
QuinStreet (NASDAQ:QNST) reported its Q2 earnings results on Tuesday, February 8, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
55 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.
24 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday.
QuinStreet Q1 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $159.60M Beat $152.31M Estimate; Raises Guidance
QuinStreet (NASDAQ:QNST) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. This is a 6.25 percent increase over earnings of $0.16 per share from the same
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
QuinStreet’s CloudControlMedia Launches New Performance Marketing Platform
Cloud Control Media, a subsidiary of QuinStreet, Inc. (NASDAQ:QNST) announces the release of CloudControlMedia Platform 3.0 (CCMP). CCMP boosts media performance and increases profits for